Global burden of metabolic-associated fatty liver disease: A systematic analysis of Global Burden of Disease Study 2021
In 2021, the number of patients affected by MAFLD was doubled compared to 1990, and the prevalence rate increased by over 50%. The burden of MAFLD, as measured by prevalence, was more prominent in countries and territories with middle SDI and in those located in North African and Middle Eastern, possibly due to changes in lifestyle in these areas over the past 30 years.
Authors
- Sitao Ye
- Mahesh Cheryala
- Xiaoquan Huang (ORCID: https://orcid.org/0000-0002-8752-4899)
- Li Tian (ORCID: https://orcid.org/0000-0002-6022-2137)
- Yichen Wang (ORCID: https://orcid.org/0000-0002-1228-0295)
- Shiyao Chen (ORCID: https://orcid.org/0000-0001-7100-957X)
- Yu-Ting Huang
Institutions
- Sun Yat-sen University (CN)
- SUNY Downstate Health Sciences University (US)
- Fudan University (CN)
- Zhongshan Hospital (CN)
- The First Affiliated Hospital, Sun Yat-sen University (CN)
- Mayo Clinic in Florida (US)
- Riverside Regional Medical Center (US)
- University of Pennsylvania (US)
Publication Details
- Journal
- Chinese Medical Journal
- Published
- 2025-04-25
- DOI
- https://doi.org/10.1097/cm9.0000000000003517
- Citations
- 4
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 5.42